ID

21453

Beschreibung

Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00283244

Link

https://clinicaltrials.gov/show/NCT00283244

Stichworte

Versionen (1)
  1. 22.04.17 22.04.17 -
Hochgeladen am

22. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lung Cancer NCT00283244

Englisch

Eligibility Lung Cancer NCT00283244

1 Formulare  
Criteria
Beschreibung

Criteria

histologically or cytologically confirmed non-small cell lung cancer (nsclc)
Beschreibung

Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0007131
stage iiib or iv disease
Beschreibung

Disease TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
measurable disease by recist criteria
Beschreibung

Measurable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
treated brain metastases allowed provided patient is asymptomatic
Beschreibung

Metastatic malignant neoplasm to brain Asymptomatic Treated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231221
UMLS CUI [1,3]
C1522326
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
anc ≥ 1,500/mm³
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count ≥ 100,000/mm³
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
hemoglobin ≥ 8.0 g/dl
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
ast and alt ≤ 2.5 times upper limit of normal (uln)
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
alkaline phosphatase ≤ 4 times uln
Beschreibung

Alkaline phosphatase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201850
creatinine ≤ 1.5 times uln
Beschreibung

Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
bilirubin normal
Beschreibung

Serum bilirubin normal

Datentyp

boolean

Alias
UMLS CUI [1]
C0428443
no history of severe hypersensitivity to gemcitabine hydrochloride
Beschreibung

Gemcitabine hydrochloride Hypersensitivity Severe Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0771488
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C0205082
UMLS CUI [1,4]
C0332197
no severe comorbid illness
Beschreibung

Comorbidity Severe Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
able to participate in quality of life assessments
Beschreibung

Participation Able Assessment of quality of life

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0085732
UMLS CUI [1,3]
C0281588
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
recovered from prior oncologic or other major surgery
Beschreibung

Neoplasm/cancer surgery Patient recovered | Major surgery Patient recovered

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0597029
UMLS CUI [1,2]
C1115804
UMLS CUI [2,1]
C0679637
UMLS CUI [2,2]
C1115804
one prior treatment for nsclc allowed provided it was in the neoadjuvant or adjuvant setting
Beschreibung

Neoadjuvant Therapy Quantity Non-Small Cell Lung Carcinoma | Adjuvant therapy Quantity Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0007131
UMLS CUI [2,1]
C0677850
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0007131
at least 1 year since prior treatment in the neoadjuvant or adjuvant setting
Beschreibung

Neoadjuvant Therapy | Adjuvant therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0600558
UMLS CUI [2]
C0677850
no other concurrent antineoplastic or antitumor agents or therapies, including chemotherapy, radiotherapy, immunotherapy, or hormonal anticancer therapy
Beschreibung

Antineoplastic Agents Absent | Cancer treatment Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent | Immunotherapy Absent | Cancer hormonal therapy Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0920425
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0021083
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0877050
UMLS CUI [6,2]
C0332197
no other concurrent investigational agents
Beschreibung

Investigational New Drugs Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0332197
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Lung Cancer NCT00283244

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Non-Small Cell Lung Carcinoma
Item
histologically or cytologically confirmed non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1])
Disease TNM clinical staging
Item
stage iiib or iv disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Measurable Disease
Item
measurable disease by recist criteria
boolean
C1513041 (UMLS CUI [1])
Metastatic malignant neoplasm to brain Asymptomatic Treated
Item
treated brain metastases allowed provided patient is asymptomatic
boolean
C0220650 (UMLS CUI [1,1])
C0231221 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Absolute neutrophil count
Item
anc ≥ 1,500/mm³
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100,000/mm³
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
hemoglobin ≥ 8.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast and alt ≤ 2.5 times upper limit of normal (uln)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Alkaline phosphatase measurement
Item
alkaline phosphatase ≤ 4 times uln
boolean
C0201850 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine ≤ 1.5 times uln
boolean
C0201976 (UMLS CUI [1])
Serum bilirubin normal
Item
bilirubin normal
boolean
C0428443 (UMLS CUI [1])
Gemcitabine hydrochloride Hypersensitivity Severe Absent
Item
no history of severe hypersensitivity to gemcitabine hydrochloride
boolean
C0771488 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Comorbidity Severe Absent
Item
no severe comorbid illness
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Participation Able Assessment of quality of life
Item
able to participate in quality of life assessments
boolean
C0679823 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C0281588 (UMLS CUI [1,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Neoplasm/cancer surgery Patient recovered | Major surgery Patient recovered
Item
recovered from prior oncologic or other major surgery
boolean
C0597029 (UMLS CUI [1,1])
C1115804 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2,1])
C1115804 (UMLS CUI [2,2])
Neoadjuvant Therapy Quantity Non-Small Cell Lung Carcinoma | Adjuvant therapy Quantity Non-Small Cell Lung Carcinoma
Item
one prior treatment for nsclc allowed provided it was in the neoadjuvant or adjuvant setting
boolean
C0600558 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
C0677850 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0007131 (UMLS CUI [2,3])
Neoadjuvant Therapy | Adjuvant therapy
Item
at least 1 year since prior treatment in the neoadjuvant or adjuvant setting
boolean
C0600558 (UMLS CUI [1])
C0677850 (UMLS CUI [2])
Antineoplastic Agents Absent | Cancer treatment Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent | Immunotherapy Absent | Cancer hormonal therapy Absent
Item
no other concurrent antineoplastic or antitumor agents or therapies, including chemotherapy, radiotherapy, immunotherapy, or hormonal anticancer therapy
boolean
C0003392 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0920425 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0021083 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0877050 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
Investigational New Drugs Absent
Item
no other concurrent investigational agents
boolean
C0013230 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video